Practicum Journal: Safe Prescribing
There is probably no greater responsibility that the psychiatric mental health nurse practitioner (PMHNP) assumes than the responsibility of prescribing medications. While someone can be harmed by psychotherapy, the level and intensity of the harm generally does not come to the same level of harm that can occur from improper prescribing. The PMHNP must understand his/her responsibility both at a state and federal level when it comes to prescribing medications.
In this Practicum Journal Assignment, you will explore the legalities associated with prescribing controlled substances, as well as what a DEA number is, how to obtain one, and, most importantly, how to prescribe controlled substances in your state.
· Analyze roles of the Drug Enforcement Administration
· Analyze PMHNP responsibilities when issued a DEA number
· Analyze DEA number application procedures
· Analyze state requirements for safe prescribing and prescription monitoring
· Analyze PMHNP responsibilities for safe prescribing and prescription monitoring
· Analyze Schedule II-V drug levels
To prepare for this Practicum Journal:
· Review the Learning Resources.
In 2-3 pages:
· Describe the role of the Drug Enforcement Administration (DEA) as it pertains to
the Psychiatric mental health nurse practitioner (PMHNP).
· Explain your responsibilities when having a DEA number.
· Explain how you apply for a DEA number.
· Explain your state’s requirements (TEXAS) for a safe prescribing and prescription monitoring program. Explain your responsibility as a PMHNP to follow these requirements.
· Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels.
N: B PLEASE INCLUDE INTRODUCTION, CONCLUSION AND REFERENCES LESS THAN 5 YEARS OLD
Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press.
To access information on specific medications, click on The Prescriber’s Guide, 5th Ed. tab on the Stahl Online website and select the appropriate medication.
Premenstrual dysphoric disorder
Seasonal affective disorder (MDD with Seasonal Variation)
Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from https://www.dea.gov/druginfo/ds.shtml